glp 1 blockers A Comprehensive Review of the Role of GLP-1 Agonists in Weight Management and Their Effect on Metabolic Parameters Such as Blood Glucose, Cholesterol, and Blood Pressure Central glucagon-like peptide 1 receptor
Description
(US) Innovent Biologics (China) Shanghai Benemae Pharmaceutical (China) PegBio Co Ltd
Statistical analyses were performed using the Student t test or ANOVA, followed by Bonferroni post tests using Prism software
Recently, there has been increased interest in the development of incretins that combine body-weight-lowering and glucose-lowering effects
10.1038/npp.2015.362 55 SharmaA
Food and Drug Administration (FDA) for reducing the risk of CV events
An overview of once-weekly glucagon-like peptide-1 receptor agonistsavailable efficacy and safety data and perspectives for the future
